ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

Senate Confirms McClellan For FDA

October 25, 2002

Mark Israel To Direct Norris Cotton Center

October 19, 2001

Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group

August 13, 1976

Court Orders Selikoff to Release Data Tapes To Tobacco Companies

August 25, 1989

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997